abrdn Healthcare Investors
NYSE:HQH

  • LAST PRICE
    17.1800
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    17.1200/ 4
  • Ask / Lots
    17.6100/ 1
  • Open / Previous Close
    --- / 17.1800
  • Day Range
    ---
  • 52 Week Range
    14.5800
    19.7900
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Recent News

0 New Today

Investment Trusts Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
HQH
abrdn Healthcare Investors
830.7M
11.9x
-7.02%
HTD
John Hancock Tax-Advantaged Dividend Income Fund
827.7M
---
---
THQ
abrdn Healthcare Opportunities Fund
815.5M
7.1x
-10.94%
AIO
Virtus Artificial Intelligence & Technology Opportunities Fund
801.5M
7.3x
---
EOI
Eaton Vance Enhanced Equity Income Fund
867.4M
4.7x
+2.50%
CII
BlackRock Enhanced Capital and Income Fund Inc
871.0M
6.0x
---
As of 2024-11-22

Company Information

abrdn Healthcare Investors (the Fund), formerly Tekla Healthcare Investors, is a non-diversified closed-end healthcare fund. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.

Contact Information

Headquarters
1900 Market Street, Suite 200PHILADELPHIA, PA, United States 19103
Phone
617-772-8515
Fax
---

Executives

Independent Chairman of the Board of Trustees
Jeffrey Bailey
President
Christian Pittard
Chief Compliance Officer, Vice President
Joseph Andolina
Vice President
Jason Akus
Vice President
Joshua Duitz

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$830.7M
Revenue (TTM)
$10.0M
Shares Outstanding
48.4M
Dividend Yield
13.27%
Annual Dividend Rate
2.2800 USD
Ex-Dividend Date
11-21-24
Pay Date
01-25-25
Beta
0.72
EPS
$1.44
Book Value
$18.84
P/E Ratio
11.9x
Price/Sales (TTM)
83.3
Price/Cash Flow (TTM)
---
Operating Margin
-11.11%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.